While we are missing our time on the road collecting data for Wave 2, it is great to see these results from Wave 1 in print. This is the result of a massive team effort (see Acknowdgements)- thank you to all involved.

Wave 2 is back on after a 6 month hiatus! The world might be operating a little differently now, but that didn’t stop us from enrolling 66 people into ETHOS over the last week at Kempsey and Port Macquarie. It feels great to be back in clinics engaging PWID with HCV care.

We enjoyed our time up in Coffs Harbour and second week back on the road with ETHOS Engage Wave 2! POC HCV RNA tests ✅ Fibroscans ✅ Big 🍌 ✅✅. Big thanks to Alex Wade and all other Mid North Coast LHD staff

Thinking of this time last week when we were on our first interstate campaign since 2019 ☀️Thank you, Youth Link Cairns! We enrolled 80 participants over 4 days. That's 80 HCV RNA tests administered in the most tropical point-of-care testing station to date🌴

Couldn't have been a better trip back to WA! Not only did we recruit 98 people between Next Step East Perth and Joondalup but we also recruited a new ETHOS team mascot. Click to reveal 😍

New study from ETHOS II ➡️ only a third of people who reported overdose in last year had ever accessed take home naloxone #InternationalOverdoseAwarenessDay Article free here: bit.ly/38uelyt Jason Grebely INHSU

Check out PhD candidate Anna Conway's important on-demand presentation at #INHSU21- using data gathered from ETHOS Engage looking at opioid overdose and naloxone access. Such important data in the context of improving well-being and health outcomes for people who inject drugs.

PhD candidate @valerio_heather will be presenting at today's Progress Toward HCV Elimination parallel session at #INHSU21. Come hear about the progress toward HCV elimination in Australia and where we need to concentrate our efforts to ensure this elimination is equitable.

Dr Alison Marshall's presentation on the willingness among people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate HCV treatment is available on-demand at #INHSU21. Grab your cup of INHSU coffee and give it a watch!

Go watch PhD student Alice Wheeler as she looks at the prevalence of drug-related hospitalisation in the ETHOS cohort in her on-demand #INHSU21 presentation. This is key data in the pursuit of improving the overall health and well-being of people who inject drugs.

A primary outcome of ETHOS Engage is treatment initiation among those who test HCV RNA positive on campaign days. Anna Conway presents this treatment uptake among the first wave of participants both 1 and 2 years post-campaign. #INHSU21 on-demand is available for the next 3 mo

Join us Nov 25, 1pm Sydney time for a focus on living experience in Spotlight on Stigma series. Facilitated by Annie Madden (PhD) AO with a dazzling range of speakers: Michelle Tobin, Tony McNaughton, Nafisa Yussf. eventbrite.com.au/e/living-exper…

✊🏽🚌🩸💉Peers On Wheels (POW) is so much more than just a van! 🥳 POW is a new pilot project NUAA has launched to deliver mobile peer-led testing and treatment services for hepatitis C (hep C).🩸👈 — It's the first of its kind in NSW! 👀 Read here: usersnews.com.au/home/peers-on-…

Awareness of HCV infection status in ETHOS Engage participants was suboptimal (65%) and lower among those with current infection (46%). Increased and simplified testing may help. We look forward to providing more point-of-care HCV testing in Wave 3! sciencedirect.com/science/articl…

ETHOS Wave III, here we go! Great to be back on the road after 2 years. Elimination is the goal. #ETHOS #NoHep #HepC #HepFreeAus

Next Tuesday at our Seminar Series, Kirby’s Anna Conway will present her research on changes to the availability of naloxone & opioid agonist treatment & the effects of the COVID-19 pandemic 📅 1pm AEDT, Tue 13 Feb 💻 Online & in-person event | Free 🗣 kirby.unsw.edu.au/events/develop…

🌈 From all of us at the Kirby Institute, we wish our LGBTQIA+ family a Happy Mardi Gras! We’re proud to work in partnership with many individuals and organisations, who help us in our mission to find effective, community-centred health solutions for infectious diseases. ‍🏳️‍🌈🏳️‍⚧️

In recognition of #InternationalWomensDay2024, NDARC invites you to join us for a discussion on the #gender-specific obstacles that women who inject drugs encounter when seeking #hepatitis C treatment and care. 🗓️ Thursday, 7 March ⏰ 3 pm 🔗us06web.zoom.us/webinar/regist…

As the world celebrated International Women’s Day, a new briefing document with World Hepatitis Alliance was released to shed light on the unique challenges faced by women living with viral hepatitis: Read it here➡️ worldhepatitisalliance.org/wp-content/upl… #Hepatitis #WomensHealth #NoHep

For more information on the issue of equitable #HCV care for women and people who use drugs, read the full study published by International Journal of Drug Policy here: 📕doi.org/10.1016/j.drug… 📕